Abstract

e16207Background: FOLFIRINOX is the standard treatment of patients with metastatic pancreatic cancer. Its effectiveness in the neoadjuvant setting in patients with (borderline) resectable pancreati...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call